Gradient Investments LLC Biomarin Pharmaceutical Inc Transaction History

Gradient Investments LLC

$3.55 Billion
Q1 2024

A detailed history of Gradient Investments LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gradient Investments LLC holds 80 shares of BMRN stock, worth $6,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 88 9.09%

Holding current value

$6,477

Previous $8,000 25.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$83.81 - $99.0 $670 - $792	-8 Reduced 9.09%	80 $6,000
Q2 2023 Jul 11, 2023	BUY	$86.68 - $100.3 $693 - $802	8 Added 10.0%	88 $7,000
Q3 2021 Oct 18, 2021	SELL	$74.77 - $85.47 $2,467 - $2,820	-33 Reduced 29.2%	80 $6,000
Q2 2021 Jul 12, 2021	SELL	$75.51 - $84.79 $1,434 - $1,611	-19 Reduced 14.39%	113 $9,000
Q1 2021 Apr 21, 2021	SELL	$74.73 - $90.69 $4.2 Million - $5.09 Million	-56,157 Reduced 99.77%	132 $10,000

Q4 2020 Jan 08, 2021	SELL	$72.61 - $90.2 $45,090 - $56,014	-621 Reduced 1.09%	56,289 $4.28 Million
Q3 2020 Oct 06, 2020	BUY	$71.87 - $131.03 $711,369 - $1.3 Million	9,898 Added 21.05%	56,910 $4.33 Million
Q2 2020 Jul 10, 2020	BUY	$79.55 - $124.22 $66,265 - $103,475	833 Added 1.8%	47,012 $5.8 Million
Q1 2020 Apr 07, 2020	BUY	$71.37 - $96.85 $286,050 - $388,174	4,008 Added 9.5%	46,179 $3.9 Million
Q4 2019 Jan 15, 2020	BUY	$64.27 - $86.37 $302,197 - $406,111	4,702 Added 12.55%	42,171 $3.57 Million
Q3 2019 Oct 10, 2019	BUY	$67.4 - $85.11 $563,531 - $711,604	8,361 Added 28.72%	37,469 $2.53 Million
Q2 2019 Jul 16, 2019	BUY	$80.35 - $93.9 $2.11 Million - $2.47 Million	26,297 Added 935.5%	29,108 $2.49 Million
Q1 2019 Apr 11, 2019	BUY	$84.2 - $98.62 $236,686 - $277,220	2,811 New	2,811 $250,000
Q3 2018 Oct 11, 2018	SELL	$93.92 - $105.72 $28,176 - $31,716	-300 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $22,803 - $29,709	300 New	300 $28,000

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Biomarin Pharmaceutical Inc Transaction History